FDA Approves Once-Daily Rheumatoid Arthritis Oral Drug, Xeljanz XR, by Pfizer

FDA Approves Once-Daily Rheumatoid Arthritis Oral Drug, Xeljanz XR, by Pfizer

Pfizer, Inc., recently announced that the U.S. Food and Drug Administration (FDA) has approved Xeljanz XR (tofacitinib citrate) extended-release 11 mg tablets as a once-daily treatment of patients with moderate to severe rheumatoid arthritis (RA) who

(Visited 2 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.